The patent relates to long-acting formulations of insulin.
Brief outline of the case
The opponent appealed the decision of maintenance according to a new MR filed during OP before the OD.
In the summons to OP before the OD, the OD held that claim 1 as granted lacked N over D1=US 2004/048783,